- Phoenix, Arizona, United States
- Hybrid
- Full-time · Mid
- 3+ years
Generate actionable intelligence on the scientific, clinical, and competitive landscape for next-generation sequencing (NGS) and other molecular diagnostic tests used in oncology.
Responsibilities
- Critically evaluate publications, clinical trials, validation studies, and congress presentations to assess assay performance, clinical validity, clinical utility, and relevance to patient care.
- Analyze developments in comprehensive genomic profiling, tissue and liquid biopsy, companion diagnostics, molecular residual disease testing, and emerging early detection approaches.
- Compare study designs, patient populations, endpoints, and methodological limitations to determine the strength of evidence supporting diagnostic claims.
- Monitor oncology testing guidelines and clinical practice developments that may affect test adoption, evidence requirements, or product positioning.
- Track competitor test launches, product enhancements, regulatory activity, partnerships, pricing, reimbursement, and commercial developments.
Requirements
- Bachelor's degree in life sciences, molecular biology, genetics, or a related field
- Nice to have: Advanced degree (MS, PhD, MD, PharmD)
- Nice to have: MBA with oncology diagnostics experience
- Nice to have: Expert interview conducting
- Nice to have: Scientific congress summary development